What are the clinical signs of gout affecting the foot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Signs of Gout in the Foot

The classic presentation of gout in the foot is acute monoarticular involvement, most commonly affecting the first metatarsophalangeal (MTP) joint (podagra), with rapid onset of severe pain and swelling reaching maximum intensity within 24 hours, accompanied by erythema. 1

Key Clinical Features

According to the 2018 EULAR guidelines, the following clinical signs strongly suggest gout when affecting the foot 1:

Acute Presentation

  • Monoarticular involvement of the first MTP joint (50% of initial attacks) or other foot/ankle joints
  • Rapid onset: Pain and swelling reach maximum severity in less than 24 hours
  • Severe pain: Often described as excruciating and unbearable 2
  • Erythema: Red, warm skin overlying the affected joint
  • Joint swelling: Marked effusion and soft tissue edema

Distribution in the Foot

Beyond the classic first MTP joint, gout commonly affects 3, 4:

  • Ankle joint
  • Midtarsal joints
  • Other metatarsophalangeal joints
  • Periarticular structures (bursae and tendons)

Chronic/Tophaceous Manifestations

In untreated or advanced disease 5, 3, 4:

  • Tophi: Firm, white/yellow subcutaneous nodules containing monosodium urate crystals
  • Chronic pain and gait impairment
  • Structural joint damage with persistent swelling
  • Cutaneous compromise: Skin breakdown over tophi with chalky discharge
  • Nail involvement: White hyperkeratotic changes, nail dystrophy, onychoschizia 6

Important Clinical Context

A critical pitfall: Hyperuricemia alone does not diagnose gout 1. The EULAR guidelines explicitly state that diagnosis should not be based on elevated uric acid levels without clinical or crystal evidence.

Diagnostic Approach

The 2017 American College of Physicians recommends synovial fluid analysis when clinical judgment indicates diagnostic testing is necessary 7. However, when aspiration is not feasible, the clinical features listed above have >80% sensitivity and specificity for diagnosis compared to crystal identification 1.

Associated Features

Male gender, cardiovascular disease, and hyperuricemia are supportive but not diagnostic features 1.

Functional Impact

Even non-tophaceous gout causes significant disability in the foot, including 5:

  • Difficulty with footwear selection
  • Gait impairment
  • Limited mobility in lower limbs
  • Impaired activities of daily living

When the clinical presentation is atypical or uncertain, ultrasound imaging should be pursued to identify the double contour sign or tophi, which are highly specific for urate crystal deposition 1, 7.

Related Questions

Which of the following statements about gout is correct?
Could the swelling and erythema of my left little toe without any injury be due to an acute gout flare?
How are acute gout, intercritical gout, and chronic tophaceous gout defined, how can patients be identified early, what comprehensive metabolic management should be employed, how should an acute gout attack be treated, which patients require prophylactic urate‑lowering therapy, what are the complications of gout, and what other crystal‑induced arthropathies should be considered?
What is the appropriate treatment for acute gout in a 70-year-old male with involvement of the left great toe?
Can erythema and edema occur with minimal or no pain, for example in gout?
In a patient 10 days after the end of her menstrual period, are low estradiol, normal follicle‑stimulating hormone (FSH), low progesterone, normal luteinizing hormone (LH), and normal testosterone levels consistent with a diagnosis of polycystic ovary syndrome (PCOS)?
How should Creon (pancrelipase) be dosed and administered in an adult with chronic kidney disease who is also taking sevelamer?
What is the best evidence‑based treatment for adjustment disorder?
What complications and clinical signs should be monitored in patients with parapelvic varices?
What is the recommended treatment for parapelvic varices?
What does a liver space‑occupying lesion with immunohistochemistry showing arginase‑1 positive, glypican‑3 positive, and cytokeratin 7 (CK7), cytokeratin 20 (CK20), HepPar‑1 (hepatocyte paraffin 1), and PAX8 negative indicate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.